The ocular adhesive market is growing rapidly due to its increasing application in treating corneal wounds and refractive surgeries. The major factors that are driving the growth of the global ocular adhesives market include the increasing cases of corneal ulcers and the rising prevalence of refractive errors. Additionally, the rising demand for ocular adhesives as an alternative to traditional wound closure procedures using sutures is driving the market. However, the high cost associated with ocular adhesives may hinder the market growth.
Ocular adhesive are often used as an alternative to the traditional wound closure techniques, i.e., sutures in ophthalmic surgery. The ocular adhesives are easy to use and can minimize complications after surgery. The ocular adhesives are non-toxic, biocompatible, easily applicable, quickly seal the surgical site, offer permeability to essential gases and nutrients, and act as a microbial barrier. Also, they are cost-effective, possess long shelf life, and ability to easily incorporate biological compounds and drugs. Owing to a wide range of advantages and characteristics, ocular adhesives are used in all ophthalmic surgeries such as refractive surgery, cataract, conjunctiva, and corneal surgeries, etc.
The ocular adhesive market is segmented based on type into natural adhesives and synthetic adhesives. Natural adhesives are usually made up of naturally derived polymers, such as proteins, polysaccharides, chondroitin, dextran, and hyaluronic acid. Whereas synthetic adhesives are based on polyethylene glycol (PEG), cyanoacrylates, dendrimer, and other synthetic polymers. Based on application, the ocular adhesive market is segmented into tissue engineering, conjunctival surgery, refractive surgery, vitreoretinal surgery, and corneal surgery. Additionally, based on the end-user, the market is segmented into hospitals, ophthalmic clinics, and ambulatory surgical centers.